Volume | 8 983 |
|
|||||
Actualités | - | ||||||
Maximum Haut | 1,11 | Bas Haut |
|||||
Minimum Bas | 1,05 |
Nom Action | Symbole Action | Marché | Type |
---|---|---|---|
Oragenics Inc | OGEN | AMEX | Action ordinaire |
Ouverture | Plus Bas | Plus Haut | Prix de clôture | Clôture Veille |
---|---|---|---|---|
1,11 | 1,05 | 1,11 | 1,09 |
Transactions Totales | Volume échangé | VWAP | Volume Financier | Volume en moyenne | Sur 52 semaines |
---|---|---|---|---|---|
135 | 8 983 | US$ 1,10 | US$ 9 846 | - | 1,015 - 7,74 |
Dernière Transaction | Type | Quantités échangées | Prix transaction | Devise |
---|---|---|---|---|
20:52:53 | 1 | US$ 1,085 | USD |
Bilan Comptable
Capitalisation Boursière | Actions en Circulation | Float | Chiffre d'affaires | Bénéfice/Perte | BPA | Ratio Cours sur Bénéfices |
---|---|---|---|---|---|---|
0 | 2,57M | - | 38k | -20,66M | - | - |
Short Interest | Dividendes Par Action | Rendement du Dividende | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
plus d’informations financières »
Actualités Action Oragenics
Date | Heure | Source | Titre |
---|---|---|---|
19/4/2024 | 23:50 | Business Wire | Oragenics, Inc. Announces Notification of Noncompliance with.. |
01/4/2024 | 15:05 | Business Wire | Oragenics, Inc. Files 10K and Provides Company Update |
18/3/2024 | 12:00 | Business Wire | Oragenics Appoints James Kelly MD, Chief Medical Officer, to.. |
06/3/2024 | 22:24 | Edgar (US Regulatory) | Form SC 13G - Statement of acquisition of beneficial.. |
05/3/2024 | 13:45 | Business Wire | Oragenics, Inc. Prepares Drug for Phase II Clinical Trials.. |
01/3/2024 | 22:04 | Business Wire | Oragenics Announces Closing of Public Offering |
29/2/2024 | 22:41 | Edgar (US Regulatory) | Form 424B5 - Prospectus [Rule 424(b)(5)] |
28/2/2024 | 15:03 | Edgar (US Regulatory) | Form 8-K - Current report |
28/2/2024 | 03:25 | Business Wire | Oragenics Announces Pricing of Public Offering |
27/2/2024 | 23:09 | Edgar (US Regulatory) | Form FWP - Filing under Securities Act Rules 163/433 of free.. |
27/2/2024 | 23:04 | Edgar (US Regulatory) | Form 424B5 - Prospectus [Rule 424(b)(5)] |
27/2/2024 | 22:33 | Business Wire | Oragenics Announces Proposed Public Offering |
Forum Action Oragenics
Aucune Discussion TrouvéeAjouter une Discussion
Historiques Oragenics Inc
Période | Ouver. | Haut | Bas | VWAP | Moyenne Vol. Quot. | Variation | % |
---|---|---|---|---|---|---|---|
1 semaine | 1,02 | 1,22 | 1,015 | 1,10 | 28 800 | 0,07 | 6,86% |
1 mois | 1,45 | 1,49 | 1,015 | 1,22 | 59 476 | -0,36 | -24,83% |
3 mois | 2,57 | 4,00 | 1,015 | 1,75 | 103 791 | -1,48 | -57,59% |
6 mois | 3,14 | 7,74 | 1,015 | 2,12 | 54 475 | -2,05 | -65,29% |
1 an | 3,21 | 7,74 | 1,015 | 2,36 | 34 459 | -2,12 | -66,04% |
3 ans | 51,108 | 69,00 | 1,015 | 37,97 | 1 171 541 | -50,02 | -97,87% |
5 ans | 31,20 | 127,20 | 1,015 | 49,56 | 3 081 024 | -30,11 | -96,51% |